539267 SAMSRITA

Samsrita Labs Share Price

 

 

Start SIP in SAMSRITA

Start SIP

Performance

  • Low
  • ₹18
  • High
  • ₹20
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹26
  • Open Price₹20
  • Previous Close₹20
  • Volume1,980
  • 50 DMA₹21.08
  • 100 DMA₹20.97
  • 200 DMA₹20.72

Investment Returns

  • Over 1 Month -4.59%
  • Over 3 Month -1.21%
  • Over 6 Month + 0.72%
  • Over 1 Year -11.09%

Smart Investing Starts Here Start SIP with Samsrita Labs for Steady Growth!

Invest Now

Samsrita Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -8.3
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 45
  • P/B Ratio
  • 3
  • Average True Range
  • 1.61
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.37
  • RSI
  • 44.08
  • MFI
  • 52.34

Samsrita Labs Financials

Samsrita Labs Technicals

EMA & SMA

Current Price
₹19.56
-0.37 (-1.86%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹20.73
  • 50 Day
  • ₹21.08
  • 100 Day
  • ₹20.97
  • 200 Day
  • ₹20.72

Resistance and Support

19.08 Pivot Speed
  • R3 21.57
  • R2 20.58
  • R1 20.07
  • S1 18.57
  • S2 17.58
  • S3 17.07

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Samsrita Labs has an operating revenue of Rs. 0.30 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of -2% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 21% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Samsrita Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-25 Quarterly Results
2025-09-08 Others Inter-alia, to consider 1. Appointment of Mrs. M. Gita usha Rani as Company Secretary and Compliance Officer of the Company. 2. Other business matters.
2025-07-18 Quarterly Results
2025-04-30 Preferential issue of shares
2025-04-26 Audited Results

Samsrita Labs F&O

Samsrita Labs Shareholding Pattern

31.41%
0%
0%
0%
0%
64.54%
4.05%

Samsrita Labs FAQs

Samsrita Labs share price is ₹19 As on 11 January, 2026 | 00:07

The Market Cap of Samsrita Labs is ₹44.5 Cr As on 11 January, 2026 | 00:07

The P/E ratio of Samsrita Labs is -8.3 As on 11 January, 2026 | 00:07

The PB ratio of Samsrita Labs is 3 As on 11 January, 2026 | 00:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23